Phase II trial of evobrutinib in multiple sclerosis
Crossref DOI link: https://doi.org/10.1038/s41582-019-0212-2
Published Online: 2019-05-24
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kelsey, Rebecca
Text and Data Mining valid from 2019-05-24
Version of Record valid from 2019-05-24
Article History
First Online: 24 May 2019
Free to read: This content has been made available to all.